Ensitrelvir, marketed as Xocova, works by inhibiting viral replication and is designed as a 5-day oral protective regimen, ...

Your daily cup of coffee could potentially double as COVID protection, a new study from China Medical University is suggesting. Previous research has shown that a diet rich in polyphenols — a class of ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, according to a study published in Nature. Using population-wide data from ...

New data released Thursday by the Centers for Disease Control and Prevention suggest that the most recent Covid-19 booster offers about 54% percent protection against infection with the virus. A study ...

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and ...

Covid vaccines continue to protect against serious illness and death, especially for people ages 65 and older, although the benefits for younger adults are not as clear, according to a large new study ...

Ducharme is a contributor to TIME. A nurse gives her patient a COVID-19 vaccine during a flu and COVID-19 vaccination clinic at Kaiser Permanente in Pasadena, Calif., on Oct. 12, 2023. Ducharme is a ...

We regularly answer frequently asked questions about life in the era of COVID-19. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject ...

A major new study examining the 2023-2024 COVID-19 vaccines shows moderate protection that works best in the first few months but weakens considerably over time. The research, published in JAMA ...

Gen. Colin Powell, former secretary of state, died Monday at 84 from COVID-related complications, though he was fully ...